Medtronic PLC (MDT) Shares Sold by Johnston Asset Management LLC

Evrard Martin
Août 9, 2017

Cullen Capital Management LLC held its stake in Medtronic PLC (NYSE:MDT) during the first quarter, Holdings Channel reports. Credit Suisse maintained the stock with "Outperform" rating in Monday, November 23 report. Johnston Asset Management LLC's holdings in Medtronic PLC were worth $25,877,000 at the end of the most recent quarter. The fund owned 1,560,427 shares of the medical technology company's stock after buying an additional 12,258 shares during the period. Vanguard Group Inc. boosted its position in Medtronic PLC by 4.5% in the first quarter. Hudock Capital Group LLC now owns 2,184 shares of the medical technology company's stock worth $175,000 after buying an additional 12 shares during the period. Cleararc Capital Inc sold 22,111 shares as Medtronic Plc (MDT)'s stock rose 5.51%. North Star Investment Management Corp. now owns 1,973 shares of the medical technology company's stock valued at $159,000 after buying an additional 83 shares during the last quarter. Massachusetts Financial Services Co.

In related news, Director Richard H. Anderson purchased 5,600 shares of Medtronic PLC stock in a transaction dated Wednesday, June 21st. Ordinary Shares (NYSE:MDT) earned "Hold" rating by Northland Capital on Friday, April 21. Baystate Wealth Management LLC now owns 1,959 shares of the medical technology company's stock valued at $157,000 after buying an additional 569 shares during the period. Mai Wealth Advisors acquired 13,428 shares as Medtronic Plc (MDT)'s stock rose 5.51%. Wells Fargo & Company MN now owns 11,932,572 shares of the medical technology company's stock valued at $961,288,000 after buying an additional 1,895,386 shares during the period. Hedge funds and other institutional investors own 83.11% of the company's stock. Ordinary Shares (NYSE:MDT). Homrich And Berg holds 0.03% in Medtronic plc. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72.

Medtronic plc. Ordinary Shares now has a P/E ratio of 28.96 and market cap is 113.72B. The firm has a 50 day moving average of $87.24 and a 200-day moving average of $82.55.

Medtronic PLC (NYSE:MDT) last issued its quarterly earnings data on Thursday, May 25th. The medical technology company reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.31 by $0.02. The business had revenue of $7.92 billion during the quarter, compared to analyst estimates of $7.86 billion. During the same quarter in the previous year, the firm posted $1.27 EPS. Medtronic PLC's revenue for the quarter was up 4.6% compared to the same quarter previous year. Equities analysts anticipate that Medtronic PLC will post $4.81 earnings per share for the current fiscal year.

Medtronic plc. Ordinary Shares recently declared a dividend which was paid on Wednesday the 26th of July 2017. Shareholders of record on Friday, July 7th will be issued a $0.46 dividend. Morgan Stanley boosted their price target on shares of Medtronic PLC from $84.00 to $86.00 and gave the company an "equal weight" rating in a report on Tuesday, May 30th. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $1.84 annualized dividend and a dividend yield of 2.18%. Medtronic PLC's payout ratio is presently 63.67%.

Nantahala Capital Management Llc holds 1.26% of its portfolio in Owens Realty Mortgage Inc for 654,968 shares.

WARNING: "TSP Capital Management Group LLC Maintains Position in Medtronic PLC (NYSE:MDT)" was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & global copyright & trademark laws. The original version of this story can be read at https://www.com-unik.info/2017/08/08/edge-asset-management-inc-has-125-71-million-stake-in-medtronic-plc-nysemdt.html.

A number of other institutional investors have also added to or reduced their stakes in MDT. Finally, Needham & Company LLC restated a "buy" rating and set a $95.00 target price (up previously from $91.00) on shares of Medtronic PLC in a report on Thursday, May 25th. BidaskClub raised shares of Medtronic PLC from a "buy" rating to a "strong-buy" rating in a research note on Saturday, June 17th. Oppenheimer Holdings, Inc. reissued a "buy" rating on shares of Medtronic PLC in a report on Tuesday, July 18th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have issued a buy rating to the stock. The stock now has an average rating of "Buy" and a consensus price target of $89.16. The stock was bought at an average cost of $88.90 per share, for a total transaction of $497,840.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

In other Medtronic PLC news, EVP Bryan C. Hanson sold 12,000 shares of the business's stock in a transaction on Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The disclosure for this purchase can be found here.

3,329 are owned by Quantitative Systematic Strategies Ltd Limited Liability Company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group and Diabetes Group.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL